Myocardial infarction in severe haemophilia

Open access


With improved replacement therapy, people with haemophilia (PWH) live longer, with the consequent emergence of age-related chronic diseases not previously seen in haemophilia. The prevalence of cardiovascular disease and associated complications in older PWH appears to be on the rise. Management of myocardial infarction in a person living with severe haemophilia presents a particular challenge, as treatment options often include antiplatelet therapy, anti-coagulation and invasive procedures. Current guidelines for managing acute myocardial infarction are not specifically designed for people with bleeding diatheses such as haemophilia. We present a patient with severe haemophilia A on extended half-life factor VIII prophylaxis who developed an acute ST-elevation myocardial infarction (STEMI), discuss his clinical management and highlight lessons learned.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Angelini D Konkle BA Sood SL. Aging among persons with hemophilia: contemporary concerns. Semin Hematol 2016; 53(1): 35-9.

  • 2. Biere-Rafi S Baarslag MA Peters M Kruip MJ et al. Cardiovascular risk assessment in haemophilia patients. Thromb Haemost 2011; 105(2): 274-8.

  • 3. Kamphuisen PW ten Cate H. Cardiovascular risk in patients with hemophilia. Blood 2014; 123(9): 1297-301.

  • 4. Sousos N Gavriilaki E Vakalopoulou S Garipidou V. Understanding cardiovascular risk in hemophilia: A step towards prevention and management. Thromb Res 2016; 140: 14-21.

  • 5. Dolan G. The challenge of an ageing haemophilic population. Haemophilia 2010; 16 Suppl 5: 11-16.

  • 6. Cerrato E Calcagno A D'Ascenzo F et al. Cardiovascular disease in HIV patients: from bench to bedside and backwards. Open Heart 2015; 2(1): e000174.

  • 7. Ibanez B James S Agewall S et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2017; 39(2): 119-77. doi:

    • Crossref
    • Export Citation
  • 8. Helft G. Dual antiplatelet therapy duration after drug-eluting stents: how long? J Thorac Dis 2016; 8(8): E844-6.

  • 9. Schutgens RE Tuinenburg A Roosendaal G Guyomi SH Mauser-Bunschoten EP. Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline. Haemophilia 2009; 15(4): 952-8.

  • 10. Philipp C. The aging patient with hemophilia: complications comorbidities and management issues. Hematology Am Soc Hematol Educ Program 2010; 2010: 191-6.

  • 11. Pocoski J Ma A Kessler CM Boklage S Humphries TJ. Cardiovascular comorbidities are increased in U.S. patients with haemophilia A: a retrospective database analysis. Haemophilia 2014; 20(4): 472-8.

Journal information
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 736 499 16
PDF Downloads 386 266 8